Search - tctmd.com

Displaying 941 - 960 of 1503

Sort: Relevancy | Date

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

October 14, 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

October 14, 2020

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

News Conference News TCT 2020

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

October 14, 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Presentation TCT 2020

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Presenter: Byeong-Keuk Kim

October 14, 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

October 14, 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

October 14, 2020

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

News Conference News TCT 2020

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

October 14, 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

October 12, 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

October 12, 2020

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

October 09, 2020

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

October 08, 2020

No Gains From Early Angiography After Cardiac Arrest Without STEMI

News Daily News

No Gains From Early Angiography After Cardiac Arrest Without STEMI

October 06, 2020

No ACS? Noninvasive Follow-up Not Helpful in Most Chest-Pain Patients

News Daily News

No ACS? Noninvasive Follow-up Not Helpful in Most Chest-Pain Patients

October 06, 2020

ESC and EACTS Announce Review of Left Main Revascularization Guidelines

News Daily News

ESC and EACTS Announce Review of Left Main Revascularization Guidelines

Michael O'Riordan

October 06, 2020

News Daily News

Radiation Doses Have Decreased Over Time for CTO Procedures

October 05, 2020

October 2020 News Roundup

News Opinion CV Team Dispatch

October 2020 News Roundup

October 01, 2020

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

News Daily News

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Michael O'Riordan

September 30, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.